TIFFANY ROULIER: Open Payments
NPI 1417517830 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 15 payments from 5 companies in 2025. Trend: 2023 $204 · 2024 $268 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $123 |
| Lilly USA, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Organon LLC | 1 | $10 |
Products named: Kerendia, Ozempic, Wegovy, MOUNJARO, CAPLYTA, NEXPLANON.
Industry payments across MS — which companies pay providers there.
